High Pines Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,077
Closed -$344K 33
2023
Q2
$344K Buy
2,077
+6
+0.3% +$968 0.52% 23
2023
Q1
$321K Buy
2,071
+13
+0.6% +$2.1K 0.53% 24
2022
Q4
$364K Buy
2,058
+2
+0.1% +$345 0.64% 16
2022
Q3
$336K Buy
2,056
+349
+20% +$59.1K 0.64% 17
2022
Q2
$303K Sell
1,707
-7,939
-82% -$1.41M 0.56% 18
2022
Q1
$1.71M Sell
9,646
-1
-0% -$170 1.26% 27
2021
Q4
$1.65M Sell
9,647
-7,668
-44% -$1.26M 1.15% 27
2021
Q3
$2.8M Buy
17,315
+4,981
+40% +$850K 1.92% 23
2021
Q2
$2.03M Sell
12,334
-3,100
-20% -$513K 1.53% 25
2021
Q1
$2.54M Buy
15,434
+7,443
+93% +$1.2M 2.24% 23
2020
Q4
$1.26M Buy
+7,991
New +$1.18M 1.16% 28

Other funds holding JNJ

High Pines Wealth Management's JNJ Position: Q3 2023 in Review

High Pines Wealth Management sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 2,077 shares — an estimated $344K sold.

High Pines Wealth Management first reported a position in JNJ in Q4 2020 and held it in 11 quarters. The position peaked at $2.8M in Q3 2021. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • High Pines Wealth Management reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • High Pines Wealth Management sold 2,077 Johnson & Johnson shares in Q3 2023, an estimated $344K.
  • High Pines Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 11 quarters.
  • High Pines Wealth Management's Johnson & Johnson position peaked at $2.8M in Q3 2021.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on High Pines Wealth Management's 13F filing for Q3 2023, filed 9 Nov 2023.